Rate of CRL4CRBN substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4Chad C. Bjorklund, Anjan Thakurta|Blood Cancer Journal|2015Cited by 216
Evidence of a Role for Activation of Wnt/β-Catenin Signaling in the Resistance of Plasma Cells to LenalidomideChad C. Bjorklund, Robert Z. Orlowski|Journal of Biological Chemistry|2010Cited by 129